9-14116313-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001190737.2(NFIB):c.1279C>T(p.Pro427Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000029 in 1,381,676 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000029 ( 0 hom. )
Consequence
NFIB
NM_001190737.2 missense
NM_001190737.2 missense
Scores
2
7
8
Clinical Significance
Conservation
PhyloP100: 9.23
Genes affected
NFIB (HGNC:7785): (nuclear factor I B) Enables DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; and transcription regulator inhibitor activity. Involved in brain development; negative regulation of DNA binding activity; and regulation of transcription by RNA polymerase II. Located in fibrillar center and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.0000146 AC: 2AN: 137286Hom.: 0 AF XY: 0.0000136 AC XY: 1AN XY: 73690
GnomAD3 exomes
AF:
AC:
2
AN:
137286
Hom.:
AF XY:
AC XY:
1
AN XY:
73690
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000290 AC: 4AN: 1381676Hom.: 0 Cov.: 31 AF XY: 0.00000441 AC XY: 3AN XY: 680906
GnomAD4 exome
AF:
AC:
4
AN:
1381676
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
680906
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 09, 2024 | The c.1279C>T (p.P427S) alteration is located in exon 9 (coding exon 9) of the NFIB gene. This alteration results from a C to T substitution at nucleotide position 1279, causing the proline (P) at amino acid position 427 to be replaced by a serine (S). Based on data from gnomAD, the T allele has an overall frequency of 0.002% (2/137286) total alleles studied. The highest observed frequency was 0.031% (2/6538) of African alleles. This amino acid position is highly conserved in available vertebrate species. The in silico prediction for this alteration is inconclusive. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;.;T;T;.;T
Eigen
Uncertain
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D;D;D
M_CAP
Benign
T
MetaRNN
Uncertain
T;T;T;T;T;T
MetaSVM
Benign
T
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N;.;.
REVEL
Uncertain
Sift
Benign
T;T;T;T;.;.
Sift4G
Benign
T;T;T;T;.;.
Vest4
MutPred
0.42
.;Gain of glycosylation at P427 (P = 0.0146);Gain of glycosylation at P427 (P = 0.0146);Gain of glycosylation at P427 (P = 0.0146);.;.;
MVP
MPC
1.5
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at